Open access
Open access
Powered by Google Translator Translator

Infectious Diseases

Randomized trial: No benefit from discontinuing ACE Inhibitors and ARBs in patients admitted with COVID-19

20 Jan, 2021 | 01:55h | UTC

Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial – JAMA

Commentary: Discontinuing vs. Continuing ACEIs, ARBs in Patients Admitted With COVID-19 – American College of Cardiology

Related study (study and commentary): Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19

 


Study: Crowded ICUs linked to increased mortality from COVID-19

20 Jan, 2021 | 01:53h | UTC

Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic – JAMA Network Open

Commentaries: Intensive Care Unit Strain and Mortality Risk Among Critically Ill Patients With COVID-19—There Is No “Me” in COVID – JAMA Network Open AND Crowded ICUs tied to higher risk of COVID-19 death – CIDRAP

 


What we know about Covid-19 reinfection so far

20 Jan, 2021 | 01:52h | UTC

What we know about covid-19 reinfection so far – The BMJ

 

Commentary on Twitter

 


SARS-CoV-2 vaccines: Much accomplished, much to learn

20 Jan, 2021 | 01:51h | UTC

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn – Annals of Internal Medicine

 

Commentary on Twitter

 


Study: Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity

20 Jan, 2021 | 01:49h | UTC

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study – The Lancet Infectious Diseases

Related Report: SARS-CoV-2 setting-specific transmission rates. Households showed the highest transmission rates (21.1%). Asymptomatic infections do occur but much less efficiently than symptomatic infection

 

Commentary on Twitter

 


Study: Immune system ‘remembers’ coronavirus for at least 6 months

20 Jan, 2021 | 01:44h | UTC

Immune system ‘remembers’ coronavirus for at least 6 months: study – MedicalXpress

Original study: Evolution of antibody immunity to SARS-CoV-2 – Nature

 

Commentary on Twitter

 


How effective is a single vaccine dose against Covid-19?

20 Jan, 2021 | 01:42h | UTC

How effective is a single vaccine dose against Covid-19? – BBC

 


What we now know — and don’t know — about the coronavirus variants

20 Jan, 2021 | 01:41h | UTC

What we now know — and don’t know — about the coronavirus variants – STAT

Related: Covid-19: What new variants are emerging and how are they being investigated? – The BMJ

 


Perspective: Covid-19 vaccine guidance for those who are lactating is based on faulty assumptions, experts say

20 Jan, 2021 | 01:40h | UTC

Covid-19 vaccine guidance for those who are lactating is based on faulty assumptions, experts say – STAT

 


Systematic review on prophylaxis for COVID-19: Hydroxychloroquine does not work, little evidence regarding other drugs

20 Jan, 2021 | 01:38h | UTC

Prophylaxis for COVID-19: a systematic review – Clinical Microbiology and Infection

 


Meta-analysis: Comparison of the loop technique with incision and drainage for skin and soft tissue abscesses

20 Jan, 2021 | 01:22h | UTC

Comparison of the Loop Technique With Incision and Drainage for Skin and Soft Tissue Abscesses: A Systematic Review and Meta‐analysis – Academic Emergency Medicine

 

Commentary on Twitter

 


WHO chief warns against ‘catastrophic moral failure’ in COVID-19 vaccine access

19 Jan, 2021 | 01:58h | UTC

WHO chief warns against ‘catastrophic moral failure’ in COVID-19 vaccine access – United Nations

Commentaries: Vaccine nationalism puts world on brink of ‘catastrophic moral failure’: WHO chief – Reuters AND Covid vaccine: WHO warns of ‘catastrophic moral failure’ – BBC

 


Evidence summary and clinical decision algorithm to guide clinicians in the care of the hypoxemic, non-intubated patients with suspected Covid-19

19 Jan, 2021 | 01:57h | UTC

Knowledge translation tools to guide care of non-intubated patients with acute respiratory illness during the COVID-19 Pandemic – Critical Care

 


Meta-analysis: Corticosteroid use in COVID-19 patients

19 Jan, 2021 | 01:56h | UTC

Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes – Critical Care

Related meta-analysis: Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials – Journal of Cardiothoracic and Vascular Anesthesia

 


IDSA: COVID-19 Diagnostic Guidelines Updates

19 Jan, 2021 | 01:54h | UTC

COVID-19 Diagnostic Guidelines Updates (Jan. 16, 2021) – Infectious Diseases Society of America

 


New calculator identifies COVID-19 patients at highest risk of deterioration

19 Jan, 2021 | 01:52h | UTC

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study – The Lancet Respiratory Medicine

Commentaries: Improving clinical management of COVID-19: the role of prediction models – The Lancet Respiratory Medicine

Tool identifies COVID-19 patients at highest risk of deterioration – UK Research and Innovation

See calculator: 4C Mortality & 4C Deterioration

 

Commentary on Twitter

 


Covid-19: What new variants are emerging and how are they being investigated?

19 Jan, 2021 | 01:51h | UTC

Covid-19: What new variants are emerging and how are they being investigated? – The BMJ

 


Rapid increase in covid cases ‘not due to the variant’, WHO says

19 Jan, 2021 | 01:49h | UTC

Rapid Increase In COVID Cases ‘Not Due To The Variant’, WHO Says – Health Policy Watch

 


Can COVID-19 cause diabetes?

19 Jan, 2021 | 01:48h | UTC

Can COVID-19 cause diabetes? – Nature Reviews Endocrinology

Related: COVID-19 and diabetes mellitus: from pathophysiology to clinical management – Nature Reviews Endocrinology

 

Commentary on Twitter

 


Meta-analysis: saliva and nasopharyngeal swab nucleic acid amplification have similar diagnostic accuracy for the detection of SARS-CoV-2

19 Jan, 2021 | 01:46h | UTC

Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis – JAMA Internal Medicine

Related: The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis – Annals of Internal Medicine

 


Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19

19 Jan, 2021 | 01:45h | UTC

Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19 – JAMA Internal Medicine

Commentary: Covid-19 Risks To Pregnant Patients. New Data Shows Risk Of Serious Complications Are Increased But Remain Rare – Brief19

 

Commentary on Twitter

 


RECOVERY trial: No Benefit from convalescent plasma in hospitalized patients with Covid-19

17 Jan, 2021 | 22:26h | UTC

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Commentary: Covid: ‘Convalescent plasma no benefit to hospital patients’ – BBC

 


WHO: Infection prevention and control guidance for long-term care facilities in the context of COVID-19 update

17 Jan, 2021 | 22:24h | UTC

Infection prevention and control guidance for long-term care facilities in the context of COVID-19 update – World Health Organization

 


Characterization of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

17 Jan, 2021 | 22:23h | UTC

Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data – The Lancet Respiratory Medicine

 

[In Portuguese] Commentary from the author on Twitter (thread – click for more)

 


Johnson & Johnson publishes early data for its Covid-19 vaccine candidate

17 Jan, 2021 | 22:22h | UTC

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine – New England Journal of Medicine

Commentaries: Johnson & Johnson Publishes Early Data For Its Covid-19 Vaccine Candidate. The Vaccine Is A Few Months Behind The MRNA Options But May Eventually Offer Advantage AND Data fuel debate over whether J&J’s one-dose Covid vaccine will measure up – STAT

 


Stay Updated in Your Specialty

No spam, just news.